plumbagin has been researched along with Skin Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dufès, C; Laskar, P; Mullin, M; Sakpakdeejaroen, I; Somani, S | 1 |
| Gowda, R; Robertson, GP; Sharma, A | 1 |
| Ahmad, A; Azmi, AS; Hadi, SM; Hanif, S; Kumar, KS; Mohammad, RM; Nazeem, S | 1 |
| Chen, R; Jiang, P; Li, J; Li, Y; Lu, J; Peng, R; Shen, Q; Zhang, L | 1 |
| Bin Hafeez, B; Fischer, J; Jamal, MS; Sand, JM; Siebers, EM; Verma, AK; Witkowsky, O | 1 |
5 other study(ies) available for plumbagin and Skin Neoplasms
| Article | Year |
|---|---|
Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Liberation; Endocytosis; Female; Humans; Injections, Intravenous; Lipids; Melanoma, Experimental; Mice, Inbred BALB C; Nanoparticles; Naphthoquinones; Polymers; Skin Neoplasms; Thiazoles; Transferrin | 2021 |
Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Melanoma; Mice, Nude; Naphthoquinones; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells.
Topics: Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Shape; Comet Assay; Copper; Cytoprotection; Free Radical Scavengers; Humans; Naphthoquinones; Neoplasms; Oxidation-Reduction; Phenanthrolines; Skin Neoplasms | 2009 |
Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Humans; Melanoma; Naphthoquinones; Receptors, TNF-Related Apoptosis-Inducing Ligand; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2010 |
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; DNA; Female; Mice; Naphthoquinones; Neoplasms, Radiation-Induced; NF-kappa B; Skin Neoplasms; STAT3 Transcription Factor; Transcription Factor AP-1; Ultraviolet Rays | 2012 |